Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
UK Research and Innovation
Grant: MR/W005611/1
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
The National Institute for Health Research Biomedical Research Centre for cancer
Grant: RMCC32
Francis Crick Institute
Grant: CC2230
Francis Crick Institute
Grant: FC001002
Francis Crick Institute
Grant: FC001030
Francis Crick Institute
Grant: FC001078
Francis Crick Institute
Grant: FC001099
Francis Crick Institute
Grant: FC001169
Francis Crick Institute
Grant: FC001218
Francis Crick Institute
Grant: FC001988
Francis Crick Institute
Grant: FC011104
Horizon 2020 Framework Programme
Grant: 892360
Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer
Royal Society
Grant: RP/EA/180007
Cancer Research UK
Grant: C50947/A18176
Institute of Cancer Research
Grant: A109
European Research Council
Grant: 835297
Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection
Rosetrees Trust
Grant: A2204
Novo Nordisk Fonden
Grant: ID16584
Breast Cancer Research Foundation
Grant: BCRF 20-157
Melanoma Research Alliance
Grant: C11496/A30025
Wellcome Trust
Grant: unidentified
unidentified
Cancer Research UK
Grant: 18176
Cancer Research UK
Grant: 29911
Medical Research Council
Grant: MR/X006751/1
Fields of Study
MeSH Terms
Keywords